Work

A phase I/II study of the combination of indoximod and temozolomide for adult patients with temozolomide-refractory primary malignant brain tumors.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.tps2107

Authors: Yousef Zakharia, Theodore S. Johnson, Howard Colman, Nicholas N. Vahanian, Charles J. Link, Eugene Kennedy, Ramses F. Sadek, Feng Ming Kong, John Vender, David Munn, Olivier Rixe

Institutions: Augusta University, University of Utah, Huntsman Cancer Institute, NewLink Genetics (United States)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603233559

Cites:

Cited by: 21

Related to: 10